Franciele Marques Vanderlei
Presidente Prudente, São Paulo, 55, Brazil
NCT Number: NCT03566186
Recent studies have shown positive results in the application of phototherapy for the improvement of performance and acceleration of the healing process of the body homeostasis. Among the methods used to assess the recovery post-exercise has cardiac autonomic modulation assessed by heart rate variability (HRV), a tool widely used in sports to evaluate medium global behavior of the autonomic nervous system. Objective: analyze and compare the effect of a special protocol of phototherapy using different light sources interacting with a combined training with an autonomic modulation of heart rate in different moments (baseline; tracking daily; recovery post-exercise and after training). Method: 45 male participants will be allocated from a stratified randomization into three groups: control (n=15), placebo (n=15) and group special protocol of phototherapy (n=15). Participants will perform a combined training of sprints and squats twice a week for twelve weeks divided into two phases. The application of phototherapy and placebo was administered in phase 2, after sprints and just before the squat. The phototherapy was used combine different light sources and wavelength (red and infrared). Was analyze HRV in five moments: baseline; traking daily; week target of phase I and II; after training. The weeks target consist of training sessions with greater energy expenditure (largest intensity). The sphericity of the data was tested by Mauchly test. In case of violation of the sphericity assumption, the correction of Greenhouse-Geisser was performed. The data was analyzed using analysis of variance for repeated measures (Bonferroni post-test), which provide information on the effects of time, group and interaction. All statistical analyzes assume the significance level of 5%.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Presidente Prudente, São Paulo, 55, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Photobiomodulation or photobiostimulation, this technique is the application of monochromatic light that can influence cellular activity through inhibition or stimulation of chemical and biological functions.
The same procedures as in the active phototherapy group was applied to the placebo group; however, the emitter was disabled. The device was emit the same sounds regardless of the programmed mode (active phototherapy).
Participants was remain sat for passive recovery supervised by an independent therapist during the period when the other groups are received recovery strategies.
Time frame: Baseline (captation of hear rate variability for 20 minutes) before 6 weeks (captation of hear rate variability for 20 minutes) and before 12 weeks (captation of hear rate variability for 20 minutes)
Analyzed and compare the effects of phototherapy with different light sources and wavelengths applied during training combined at heart rate variability
Time frame: During training sessions with higher energetic spending leaving for the last two weeks, composed of higher intensity - (captation of hear rate variability for 1 hour on phase 1 and phase 2).
Compare the effects of phototherapy with placebo group and control group at recovery after exercise of heart rate variability.
Time frame: daily, after exercise and before exercise (captation of hear rate variability for 7 minutes)
Analyze and compare the change in the indices of heart rate variability in tracking daily after combined training of sprints and squats
Paulista University
Other
Effects of Phototherapy Associated With Sprint and Squat Training on Cardiac Autonomic Modulation: Randomized, Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06921330
ABO Incompatibility, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT07266246
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07388732
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyper Bilirubinemia
Kütahya, Province, Turkey (Türkiye)
View Trial DetailsNCT05556811
Confusion, Critical Care
Berlin, Germany
View Trial Details